These are five of the Most Active Penny Stocks in October that investors may find worthy of investment for 2024 and beyond
December S&P 500 futures (ESZ23) are down -0.40%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.53% this morning as market participants continued to price in an extended period of elevated...
Continued focus and progress with FemaSeed® and FemBloc® biomedical product candidates in developmentFemCerv® and FemCath™ commercial availability expected...
Webinar to be held Thursday, July 28th @ 10:30am EDT...
ATLANTA, July 11, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite...
Recent events, particularly the reversal of the long-standing Roe v. Wade decision that guaranteed women’s right to have an abortion, have put women’s health matters squarely in the spotlight. It also...
- Furthers advancement of much-needed minimally invasive technologies for underserved areas of women’s health with pending commercialization of products,...
ATLANTA, March 25, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a...
-- Company builds out management team and continues to implement its clinical programs to advance much-needed technologies for women’s health -- ATLANTA,...
ATLANTA, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite...